[go: up one dir, main page]

EP1372630A4 - AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER - Google Patents

AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER

Info

Publication number
EP1372630A4
EP1372630A4 EP02728597A EP02728597A EP1372630A4 EP 1372630 A4 EP1372630 A4 EP 1372630A4 EP 02728597 A EP02728597 A EP 02728597A EP 02728597 A EP02728597 A EP 02728597A EP 1372630 A4 EP1372630 A4 EP 1372630A4
Authority
EP
European Patent Office
Prior art keywords
agent
treatment
hyperactive bladder
hyperactive
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02728597A
Other languages
German (de)
French (fr)
Other versions
EP1372630A2 (en
Inventor
Tsuyoshi Yamagata
Kaoru Atsuki
Tetsuji Ohno
Shiro Shirakura
William C Degroat
Adrian Sculporeanu
Akira Karasawa
Naoki Yoshimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
University of Pittsburgh
Original Assignee
Kyowa Hakko Kogyo Co Ltd
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd, University of Pittsburgh filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of EP1372630A2 publication Critical patent/EP1372630A2/en
Publication of EP1372630A4 publication Critical patent/EP1372630A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP02728597A 2001-03-30 2002-03-29 AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER Withdrawn EP1372630A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27969801P 2001-03-30 2001-03-30
US279698P 2001-03-30
PCT/US2002/009577 WO2002078523A2 (en) 2001-03-30 2002-03-29 Agent for the treatment of overactive bladder

Publications (2)

Publication Number Publication Date
EP1372630A2 EP1372630A2 (en) 2004-01-02
EP1372630A4 true EP1372630A4 (en) 2005-03-23

Family

ID=23070051

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02728597A Withdrawn EP1372630A4 (en) 2001-03-30 2002-03-29 AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER

Country Status (4)

Country Link
EP (1) EP1372630A4 (en)
JP (1) JP2005506296A (en)
CA (1) CA2442437A1 (en)
WO (1) WO2002078523A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388898B (en) * 2002-04-02 2005-10-05 Inverness Medical Ltd Integrated sample testing meter

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046587A1 (en) * 1997-04-15 1998-10-22 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046587A1 (en) * 1997-04-15 1998-10-22 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
EP0979821A1 (en) * 1997-04-15 2000-02-16 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GRANT T L ET AL: "ANILIDE TERTIARY CARBINOLS: A NOVEL SERIES OF K+ CHANNEL OPENERS", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 15, no. 11, 1 November 1994 (1994-11-01), pages 402 - 404, XP000566910, ISSN: 0165-6147 *

Also Published As

Publication number Publication date
WO2002078523A2 (en) 2002-10-10
JP2005506296A (en) 2005-03-03
WO2002078523A3 (en) 2003-07-24
EP1372630A2 (en) 2004-01-02
CA2442437A1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
NO20035156D0 (en) Well treatment procedures
ATE439844T1 (en) COMBINATIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES
ATE345331T1 (en) COMPOUNDS USABLE FOR THE TREATMENT OF INFLAMMATORY DISEASES
BRPI0307673A2 (en) methods of treating vascular disease.
IL229160B (en) Rapamycin derivatives for the treatment of solid tumors
EP1643986A4 (en) PHENYLCARBOXYLATE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
NO20021526L (en) Sewage treatment device
ATE551340T1 (en) AZABICYCLIC SUBSTITUTED ANNATED HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASES
DE60325498D1 (en) 1-ACYL-PYRROLIDIN DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
DE60218493D1 (en) SUBSTITUTED 7-AZA-Ä2.2.1ÜBICYCLOHEPTANE FOR THE TREATMENT OF DISEASES
EP1656359A4 (en) MACROCYCLIC BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DE60239558D1 (en) COMBINATIONS FOR THE TREATMENT OF IMMUNO-INFLAMMATORY DISEASES
IS6917A (en) Epothilone derivatives for the treatment of difficult tumors
EP1485109A4 (en) VASCULAR TREATMENT
PT1206436E (en) RETINOIDS FOR THE TREATMENT OF ENFISEMA
ATE276262T1 (en) OXAZINOQUINOLONES FOR THE TREATMENT OF VIRAL INFECTIONS
DE60220297D1 (en) LAUNDRY TREATMENT AGENT
DE60227963D1 (en) TREATMENT SYSTEM
DE60220220D1 (en) Blood treatment system
DE60222664D1 (en) SKIN TREATMENT AGENT
IT1306165B1 (en) USE OF INHIBITORS OF THE SUBSTANCE P FOR THE TREATMENT OF DENOCARCINOMAS.
EP1231840A4 (en) ANTI-ANGIOGENIC CELLULAR AGENT FOR THE TREATMENT OF CANCER
ITGE20020050A0 (en) PROCEDURE FOR THE TREATMENT OF YARNS BY NEEDLETING.
DE60324591D1 (en) LAUNDRY TREATMENT AGENT
EP1372630A4 (en) AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031029

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050209

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 495/04 B

Ipc: 7A 61P 13/10 B

Ipc: 7A 61K 31/18 A

17Q First examination report despatched

Effective date: 20050601

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051012